1. Home
  2. IMRN vs HTOO Comparison

IMRN vs HTOO Comparison

Compare IMRN & HTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • HTOO
  • Stock Information
  • Founded
  • IMRN 1994
  • HTOO 2020
  • Country
  • IMRN Australia
  • HTOO Ireland
  • Employees
  • IMRN N/A
  • HTOO N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • HTOO Natural Gas Distribution
  • Sector
  • IMRN Health Care
  • HTOO Utilities
  • Exchange
  • IMRN Nasdaq
  • HTOO Nasdaq
  • Market Cap
  • IMRN 14.4M
  • HTOO 8.4M
  • IPO Year
  • IMRN N/A
  • HTOO N/A
  • Fundamental
  • Price
  • IMRN $2.15
  • HTOO $4.84
  • Analyst Decision
  • IMRN
  • HTOO
  • Analyst Count
  • IMRN 0
  • HTOO 0
  • Target Price
  • IMRN N/A
  • HTOO N/A
  • AVG Volume (30 Days)
  • IMRN 94.3K
  • HTOO 112.7K
  • Earning Date
  • IMRN 08-29-2025
  • HTOO 02-28-2023
  • Dividend Yield
  • IMRN N/A
  • HTOO N/A
  • EPS Growth
  • IMRN N/A
  • HTOO N/A
  • EPS
  • IMRN N/A
  • HTOO N/A
  • Revenue
  • IMRN $4,777,422.00
  • HTOO $10,024,662.00
  • Revenue This Year
  • IMRN N/A
  • HTOO $4,832.46
  • Revenue Next Year
  • IMRN N/A
  • HTOO $81.82
  • P/E Ratio
  • IMRN N/A
  • HTOO N/A
  • Revenue Growth
  • IMRN 48.63
  • HTOO 105.98
  • 52 Week Low
  • IMRN $1.50
  • HTOO $3.41
  • 52 Week High
  • IMRN $2.48
  • HTOO $28.35
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 55.04
  • HTOO 52.95
  • Support Level
  • IMRN $2.06
  • HTOO $4.50
  • Resistance Level
  • IMRN $2.25
  • HTOO $5.20
  • Average True Range (ATR)
  • IMRN 0.14
  • HTOO 0.32
  • MACD
  • IMRN -0.01
  • HTOO -0.04
  • Stochastic Oscillator
  • IMRN 42.50
  • HTOO 48.49

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About HTOO Fusion Fuel Green PLC

Fusion Fuel Green PLC is a provider of full-service energy engineering and advisory solutions, specializing in green hydrogen and industrial gas applications. It offers a broad portfolio of services, including the design, supply, installation, and maintenance of energy systems, as well as the transport and distribution of liquefied petroleum gas. The company serves a diverse customer base spanning commercial buildings, mixed-use developments, heavy industries, and food service sectors. The group currently derives revenue by providing comprehensive solutions for the liquefied petroleum gas (LPG) industry, which includes the supply, installation, and maintenance of LPG systems, as well as transportation and delivery of LPG in both bulk and cylinder formats.

Share on Social Networks: